Interferon beta-1b (Nuron Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1b (Nuron Biotech)
Drug Alias NameRelonsivRecombinant human interferon beta - BaroFold/Nuron BiotechInterferon beta-1b - Nuron Biotech/BaroFoldBaroFeronNU-100
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBarofold
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBarofoldNuron Biotech Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksWikipedia